Drug Shortage Report for PACLITAXEL INJECTION USP
| Report ID | 225231 |
| Drug Identification Number | 02391465 |
| Brand name | PACLITAXEL INJECTION USP |
| Common or Proper name | PACLITAXEL |
| Company Name | ACCORD HEALTHCARE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | PACLITAXEL |
| Strength(s) | 6MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 50ML |
| ATC code | L01CD |
| ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | 2024-08-19 |
| Actual start date | 2024-08-23 |
| Estimated end date | 2024-10-25 |
| Actual end date | 2024-10-25 |
| Shortage status | Resolved |
| Updated date | 2024-10-26 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.